Recent HBIO Stock Price | HBIO Stock Predictions | |
$3.72 | +86.02% |
$6.92 |
Recent HBIO Analyst Ratings Breakdown, Making HBIO Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 2 | 2 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the HBIO stock predictions from the analysts covering Harvard Bioscience Inc., we have collected all of the individual HBIO stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 3 different analysts covering HBIO (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since HBIO stock predictions may vary widely, another useful metric to consider is the median HBIO stock prediction, which represents the price at which half of the analysts
made HBIO stock predictions that were higher and half made HBIO stock predictions that were lower. This makes for a different take on the HBIO stock predictions out there, as compared to average or mean.
And that median across all the individual HBIO stock predictions was: $7.0 as of 2024-04-24.
The very highest of the HBIO stock predictions for one year price target was $7.0, while the very lowest of the HBIO stock predictions in the analyst group was
$6.75 (with a standard deviation of $0.144). Get the latest Zacks research report on HBIO — FREE
Find out: HBIO next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
EMKR Stock Predictions
VIE Stock Predictions
NNBR Stock Predictions
LIQT Stock Predictions
WOW Stock Predictions
AXLA Stock Predictions
ALLY Stock Predictions
UCBI Stock Predictions
INDB Stock Predictions
|
|
Strong Buy (4.00 out of 4) 91st percentile
(ranked higher than approx. 91% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |